Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Methandrostenolone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 9/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | GUSB | P08236 | 1/20 | 0.65 |
| ▸ | SHBG | P04278 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.60 |
| ▸ | PGR | P06401 | 2/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | HTR2B | P41595 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methandrostenolone SCHEMBL28423591 | 1.00 | LMNA (1.00) | LMNAMAPTCYP19A1CYP3A4GUSB | |
| Methandrostenolone SCHEMBL8408550 | 1.00 | LMNA (1.00) | LMNAMAPTCYP19A1CYP3A4GUSB | |
| Methandrostenolone SCHEMBL21177905 | 1.00 | LMNA (1.00) | LMNAMAPTCYP19A1CYP3A4GUSB | |
| Methandrostenolone SCHEMBL4435272 | 1.00 | LMNA (1.00) | LMNAMAPTCYP19A1CYP3A4GUSB | |
| Methandrostenolone SCHEMBL16755284 | 1.00 | LMNA (1.00) | LMNAMAPTCYP19A1CYP3A4GUSB | |
| Methandrostenolone SCHEMBL6395376 | 0.90 | LMNA (0.81) | LMNAMAPTCYP19A1CYP3A4GUSB | |
| SCHEMBL5270893 | 0.90 | LMNA (0.81) | LMNAMAPTCYP19A1CYP3A4ALDH1A1 | |
| SCHEMBL10861103 | 0.90 | LMNA (0.81) | LMNAMAPTCYP19A1CYP3A4ALDH1A1 | |
| SCHEMBL17775770 | 0.87 | LMNA (0.77) | LMNAMAPTCYP19A1CYP3A4 | |
| SCHEMBL27046922 | 0.86 | LMNA (0.75) | LMNAMAPTCYP19A1CYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3084 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119570811-A | Vinca EIN3-EILs transcription factor and application thereof | 上海交通大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119202111-A | Knowledge graph-based arch dam abutment unfavorable structural surface treatment measure recommendation method and terminal equipment | 中国电建集团中南勘测设计研究院有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-20240358719-A1 | Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-10-31 | — | — | US | claimed |
| EP-3863708-B1 | MIXED IONIC CONDUCTORS AND CORRESPONDING DEVICES, SYSTEMS AND METHODS OF MAKING | BATTELLE MEMORIAL INSTITUTE (US) | 2024-09-11 | — | — | EP | claimed |
| EP-3612223-B1 | TREATING MALE SENESCENCE | NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) | 2024-07-31 | — | — | EP | claimed |
| CN-118154052-A | Power distribution network power exchange station site selection planning method considering centralized charging mode | 国网湖北省电力有限公司电力科学研究院 | 2024-06-07 | — | — | CN | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| CN-117630146-A | Nondestructive testing method for pollutants in aquatic products | 北京市农产品质量安全中心 | 2024-03-01 | — | — | CN | claimed |
| EP-4313061-A1 | FORMULATIONS FOR PROLONGING GESTATION AND FOR COMPLICATIONS OF MENSTRUATION OR GESTATION | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-02-07 | — | — | EP | claimed |
| US-20230301931-A1 | NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2023-09-28 | — | — | US | claimed |
| EP-0240904-B1 | PROCESS FOR THE PREPARATION OF SOLID PHARMACEUTICAL FORMS | BASF Aktiengesellschaft (DE) | 1992-07-01 | — | — | EP | claimed |
| US-5073379-A | Melts, extrusion, rolling. tablets | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-17 | — | — | US | claimed |
| US-5071657-A | DEVICE FOR TRANSDERMAL ADMINISTRATION OF ACTIVE MEDICINAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-12-10 | — | — | US | claimed |
| US-5026692-A | Prevention and treatment of immunodeficiency diseases | RESEARCH DEVELOPMENT CORPORATION OF JAPAN (JP) | 1991-06-25 | — | — | US | claimed |
| EP-0199768-A4 | A METHOD FOR THE PREVENTION OF OCULAR HYPERTENSION, TREATMENT OF GLAUCOMA AND TREATMENT OF OCULAR HYPERTENSION. | KNEPPER PAUL A | 1989-04-26 | — | — | EP | claimed |
| US-4801460-A | N-VINYLPYRROLIDONE POLYMER BINDER | BASF AKTIENGESELLSCHAFT (DE) | 1989-01-31 | — | — | US | claimed |
| EP-0199768-A1 | A METHOD FOR THE PREVENTION OF OCULAR HYPERTENSION, TREATMENT OF GLAUCOMA AND TREATMENT OF OCULAR HYPERTENSION | KNEPPER, Paul A. (US) | 1986-11-05 | — | — | EP | claimed |
| US-4617299-A | ADMINISTERING SELECTED ANABOLIC ANDROGENIC COMPOUNDS | KNEPPER PAUL A (US) | 1986-10-14 | — | — | US | claimed |
| WO-1986002554-A1 | A METHOD FOR THE PREVENTION OF OCULAR HYPERTENSION, TREATMENT OF GLAUCOMA AND TREATMENT OF OCULAR HYPERTENSION | KNEPPER PAUL A | 1986-05-09 | — | — | WO | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |